Therapeutics: Catechol-O-methyl-transferase (COMT)

Neurology

INDICATION: Parkinson's disease (PD)

In vitro studies identified a thiazolidinedione-based COMT inhibitor that could

Read the full 134 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE